Literature DB >> 11734747

Hepatitis A vaccine in pediatric patients affected by metabolic liver diseases.

R Giacchino1, A Timitilli, E Castellano, M Di Rocco, P Fiore, R Soncini, L Romanò.   

Abstract

Twenty children with a variety of metabolic liver diseases were given two doses of hepatitis A vaccine. Adverse reactions were mild. All subjects responded to vaccine with seroconversion to hepatitis A virus antibodies after the first dose, regardless of transaminase values, and had a booster effect from the second doses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734747     DOI: 10.1097/00006454-200108000-00018

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  1 in total

1.  Safety and efficacy of hepatitis A vaccine in children with chronic liver disease.

Authors:  Hanaa-Mostafa El-Karaksy; Manal-Ismail El-Hawary; Nehal-Mohammad El-Koofy; Rokaya El-Sayed; Mona-Al-Saeed El-Raziky; Samah-Asaad Mansour; Gamal-Mohammad Taha; Fatma El-Mougy
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.